Keywordsbiomarker; Zn; LA:DGLA; Zn status; fatty acid; zinc; visceral adipose tissue; hypertrophy; glucose clearance; leptin; IL6; AKT; Zn deficiency; TRH; TSH; subclinical hypothyroidism; zinc; diabetes mellitus; insulin; insulin resistance; inflammation; immune response; anti-oxidant; tissue proliferation; matrix remodelling; TRIM family proteins; matrix metalloproteinase; diet; cohort; Australia; zinc; women; cardiovascular disease; zinc deficiency; HCV-related chronic liver disease; nonalcoholic steatohepatitis; liver cirrhosis; insulin resistance; hepatic steatosis; hepatic encephalopathy; iron overload; lipid peroxidation; insulin-like growth factor-1; zinc; validation study; ZINC-FFQ; food frequency questionnaire; validity; reproducibility; zinc; multiple micronutrient powder; diarrhea; linear growth; infants; exchangeable zinc pool size; zinc; copper; synapse; amyloid; apoptosis; ER stress; food analysis; zinc; skin; acrodermatitis enteropathica; Langerhans cells; ATP; nutrition; zinc; skin; homeostasis; transporter; zinc status; plasma zinc; toddlers; food fussiness; red meat; infant formula; zinc intake; complementary feeding; nutrition; micronutrient; diet; depression; zinc; magnesium; selenium; microbiota
